Related Experiment Video
Updated: Jun 6, 2025

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Conduction system pacing in heart failure: Time for a paradigm shift?
Panayotis K Vlachakis1, Panagiotis Theofilis2, Anastasios Apostolos2
1First Department of Cardiology, National and Kapodistrian University of Athens, School of Medicine "Hippokration" General Hospital, 114 Vasilissis Sofias avenue, Athens, 11527, Greece. vlachakispanag@gmail.com.
Insights
Conduction system pacing (CSP) shows promise for heart failure (HF) patients with electrical issues. Further research, including randomized controlled trials (RCTs), is needed to confirm long-term benefits and refine techniques for widespread clinical use.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Heart failure (HF) presents significant morbidity and mortality, often linked to electrical conduction abnormalities.
- Conventional pacing techniques may yield suboptimal outcomes in HF patients with these abnormalities.
- Conduction system pacing (CSP) offers a novel approach targeting the heart's natural conduction system.
Purpose of the Study:
- To review the current status and future directions of conduction system pacing (CSP) in heart failure (HF) management.
- To highlight the potential benefits and existing challenges of CSP for HF patients.
- To emphasize the need for further research, particularly randomized controlled trials (RCTs).
Main Methods:
- Review of current literature and observational studies on CSP in HF.
- Analysis of recent guideline recommendations regarding CSP.
- Discussion of technical challenges and future technological integration in CSP.
Main Results:
- CSP, including His bundle pacing and left bundle branch area pacing, is recommended for specific HF populations based on observational data.
- Existing data are primarily from observational studies, limiting definitive conclusions on long-term outcomes.
- Technical challenges in lead implantation and mechanical stress require further investigation.
Conclusions:
- CSP holds potential for improving HF management by addressing electrical conduction abnormalities.
- Routine clinical implementation requires clarification of practical considerations and resolution of technical challenges.
- Large-scale RCTs are crucial to establish efficacy, identify optimal candidates, and guide future CSP practices in HF.
Abstract:
Heart failure (HF) is a major clinical challenge characterized by significant morbidity and mortality. Electrical conduction abnormalities play a critical role in HF pathophysiology and progression, often leading to suboptimal outcomes with conventional pacing techniques. Con-duction system pacing (CSP), encompassing His bundle pacing and left bundle branch area pacing, has emerged as a novel approach. Despite data come from observational studies, recent guidelines recommend that a specific population may benefit from CSP. However, significant practical considerations and challenges need to be clarified before CSP can be routinely implemented in clinical practice. The reliance on observational studies means that long-term clinical outcomes for HF patients remain uncertain until data from randomized controlled trials (RCTs) become available. Current CSP practices face challenges with lead implantation, mechanical stress on leads, and the need for more advanced tools and artificial intelligence integration to improve procedure efficacy and safety. Future large-scale RCTs are essential to identify optimal candidates and address these technical challenges, potentially leading to a paradigm shift in HF management.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
07:49Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
Related Concept Videos
Conduction System of the Heart
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
Pathophysiology of Heart Failure
Heart Failure Drugs: Inotropic Agents
Electrophysiology of Normal Cardiac Rhythm
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure Drugs: β-Blockers